Antibody Expression for National Research Programs

We have an established track record of partnering with national laboratories and public health institutes across the Americas, Europe, and Asia. Our team is experienced in navigating the specific administrative requirements of international government tenders, including the provision of multi vendor quotations and adherence to formal procurement frameworks.

We understand that government institutions must adhere to standardized frameworks and often require multiple vendor quotes before proceeding. Our team provides comprehensive and fixed price quotations that include detailed technical specifications and clear deliverables to facilitate your internal review and approval process.

Every project follows a standardized and validated workflow that captures every detail of the production and purification process. We provide a comprehensive Certificate of Analysis along with detailed batch records and full material traceability to satisfy the most rigorous institutional oversight requirements.

Yes, we provide comprehensive Certificates of Analysis and detailed batch records for every production run. Our data is generated in an industry standard CHO environment, ensuring that your research documentation is directly relevant for subsequent regulatory evaluations and future manufacturing transitions.

Every project follows a standardized and validated Swiss workflow designed for high stakes research. While we operate in the research and preclinical space, our internal quality management ensures material traceability and consistency that meet the rigorous expectations of governmental audit and oversight bodies.

Most therapeutic antibodies are manufactured in CHO cells which makes this host system the global industry standard for regulatory science. Generating your research data in a CHO based environment ensures that your results are directly relevant to real world therapeutic contexts and future manufacturing success.

We operate with the highest level of discretion and are prepared to enter into specialized confidentiality agreements tailored to sensitive institutional requirements. All project related communication and data handling follow strict internal security protocols to protect the integrity of your research.

We utilize a 100% cell based and animal free expression system that reflects the evolving ethical standards of national laboratories and global research institutions. This commitment ensures that your program remains compliant with modern sustainability mandates while maintaining the highest levels of scientific purity.

Consistency is a hallmark of our Swiss facility and we maintain the same validated protocols across all production runs to eliminate experimental variability. Our track record of over 140,000 transfections demonstrates our ability to deliver reproducible results year after year to provide a reliable foundation for longitudinal studies.

We treat all sequence information and project details with the highest level of confidentiality within our secure Swiss infrastructure. Our internal protocols ensure that sensitive research data remains protected throughout the production lifecycle to meet the stringent security requirements of national laboratories.

We provide transparent and fixed price quotations based on the technical specifications and scale of each individual project. This approach ensures financial predictability and allows institutional managers to align their research needs with public funding cycles and mandatory budgetary requirements.

Our facility supports project requirements ranging from small pilot studies to large scale production up to 10 g per batch. This versatility allows institutions to transition seamlessly from initial screening to extensive validation studies within a single specialized platform.

While we maintain a standard four week timeline for recombinant expression our project initiation begins within 24 hours of receiving formal approval at our Zurich facility. This rapid execution ensures that logistical delays are minimized so that essential research can proceed without unnecessary interruptions.

We are prepared to engage in long term strategic partnerships through framework agreements that streamline the ordering process for recurring institutional needs. These arrangements provide your department with consistent pricing and prioritized scheduling to ensure that multi year research initiatives remain on track.

All sequence data and project records are managed within our secure IT infrastructure in Switzerland. We utilize advanced encryption and access controls to ensure that your intellectual property remains protected from the initial inquiry through to the final delivery of your purified antibodies.